Abstract: The present invention relates to a method and apparatus for the encapsulation of biologically-active substances in a red blood cell, characterized by an optionally automated, continuous-flow, self-contained electroporation system which allows withdrawal of blood from a patient, separation of red blood cells, encapsulation of a biologically-active substance in the cells, and optional recombination of blood plasma and the modified cells, thereby producing blood with modified biological characteristics. The present invention is particularly suited for use to encapsulate allosteric effectors of hemoglobin, thereby reducing the affinity of erythrocytes for oxygen and improving the release of oxygen from erythrocytes in tissues.
Type:
Grant
Filed:
December 18, 1995
Date of Patent:
March 18, 1997
Assignee:
CBR Laboratories, Inc.
Inventors:
Yves C. Nicolau, Ulrich Bruggemann, Youssef Mouneimne, Eric C. Roux